Esphera’s platform generates exosomes that deliver precise payloads to targeted cells, including tumor and immune cells. These payloads, which range from enzymes to RNAs, enhance existing immunotherapies, vaccines, gene therapies, and enzyme replacement therapies. This innovative technology aims to improve cancer immunotherapy and provide a new approach to cellular medicine.